{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-286737","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2026-06-29T10:03:19+00:00","discovered_at":"2026-06-29T10:05:00.218391+00:00","generated_at":"2026-06-29T10:05:11.767626+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Decoy Therapeutics raises $3.5M upfront in PIPE, up to $21M with milestone warrants","bullets":["Gross proceeds of $3.5M from sale of 592,217 shares (or pre-funded warrants) at $5.91/share.","Milestone warrants could add $3.5M (Series A), $7.0M (Series B), and $7.0M (Series C) if triggered.","Proceeds to advance lead asset into clinical trials; closing expected June 29, 2026.","Executives and directors subject to 90-day lock-up; Curvature Securities acting as placement agent.","Registration rights agreement requires filing resale registration statement within 15 calendar days."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-286737","json":"https://secwatch.observer/filing/0001193125-26-286737.json","markdown":"https://secwatch.observer/filing/0001193125-26-286737.md","text":"https://secwatch.observer/filing/0001193125-26-286737.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000119312526286737/0001193125-26-286737-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000119312526286737/dcoy-20260626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T10:05:11.767626+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}